Acumen Hypotension Prediction Index (HPI) Feature Software vs Viz HCM

Viz HCM offers broader and more flexible usability through its cloud-based platform, seamless integration with EHR/PACS, and mobile-based alerts for multidisciplinary care teams. This allows for wider accessibility across various clinical settings and devices. While Acumen HPI is well-integrated into the Edwards Lifesciences HemoSphere platform, its use is more confined to that specific monitoring environment.

Both tools provide significant clinical value. Acumen HPI demonstrably reduces the incidence, duration, and severity of intraoperative hypotension, improving acute patient outcomes. However, Viz HCM addresses the critical public health issue of underdiagnosed Hypertrophic Cardiomyopathy by enabling earlier detection (potentially years in advance) and coordinating care across the health system, which can profoundly alter the disease course and improve long-term patient quality of life and longevity.

Viz HCM provides greater transparency and a clearer value proposition by disclosing its subscription-based pricing model and, notably, the availability of CMS reimbursement for specific CPT codes (effective January 1, 2025). This offers a tangible financial benefit and pathway for adoption by healthcare systems. Acumen HPI's pricing information is not publicly available, requiring direct vendor contact, which makes a direct comparison of value challenging.

While both tools are FDA-cleared, HIPAA compliant, and offer BAAs, Viz HCM demonstrates superior enterprise readiness due to its cloud-based deployment and proven integration with existing hospital IT systems like EHR and PACS across nearly 1,300 hospitals. This broad integration capability and scalability make it more adaptable to diverse health system infrastructures. Acumen HPI's integration is primarily within the proprietary Edwards Lifesciences HemoSphere platform, which may limit its broader enterprise-wide deployment.

Acumen HPI was a pioneering 'first-of-its-kind' technology for predictive hypotension using machine learning on blood pressure waveforms, representing a significant advancement in acute care. Viz HCM, however, not only innovates with its 'first and only FDA-cleared AI algorithm' for real-time ECG analysis of HCM but also extends this innovation to intelligent care coordination, automated patient direction to specialists, and mobile alerts for multidisciplinary teams, addressing a broader systemic challenge in patient management. This comprehensive approach to detection and workflow integration gives Viz HCM a slight edge in overall innovation.

Viz HCM appears to offer more comprehensive and readily accessible support resources, including a dedicated online 'Knowledge Base' with 'Help Center,' 'Tips & tutorials,' and 'Troubleshooting' sections, along with 'User Guides' and 'Viz Academy'. While Acumen HPI provides 'Instructions For Use' and a 'Setup Guide', the breadth of publicly available support information for Viz HCM suggests a more robust and user-friendly support ecosystem.